Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew C Cheung

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Practical Radiation Oncology|March 23, 2021
Mammographic Surveillance in Older Women With Breast Cancer in Canada and the United States: Are We Choosing Wisely?Danielle Rodin, Rachel M Glicksman, Kathryn Clark, et al.
British Journal of Haematology|August 2, 2012
Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literatureHany R Guirguis, Matthew C Cheung, Mervat Mahrous, et al.
Annals of Hematology|January 14, 2014
Survival of patients with transformed lymphoma in the rituximab eraHany R Guirguis, Matthew C Cheung, Eugenia Piliotis, et al.
BMC Cancer|November 5, 2022
Primary care utilization for patients with newly diagnosed cancer during the COVID-19 pandemic: a population-based studyYing Ling, Matthew C Cheung, Kelvin K W Chan, et al.
BMJ Open|November 3, 2021
Importance of accounting for loss to follow-up when comparing mortality between immigrants and long-term residents: a population-based retrospective cohortManav V Vyas, Jiming Fang, Peter C Austin, et al.
Intensive Care Medicine|September 14, 2021
Critical illness in patients with hematologic malignancy: a population-based cohort studyBruno L Ferreyro, Damon C Scales, Hannah Wunsch, et al.
Cancer Medicine|December 1, 2021
Examining the association between oncology drug clinical benefit and the time to public reimbursementSasha Thomson, Louis Everest, Noah Witzke, et al.
Journal of the National Cancer Institute|April 28, 2022
An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical TrialsMathew Hall, Vaishali A Krishnanandan, Matthew C Cheung, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2021
Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over timeSasha Thomson, Noah Witzke, Bishal Gyawali, et al.
Annals of Hematology|March 21, 2007
Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphomaMatthew C Cheung, Kevin R Imrie, Heather A Leitch, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Practical Radiation Oncology|March 23, 2021
Mammographic Surveillance in Older Women With Breast Cancer in Canada and the United States: Are We Choosing Wisely?Danielle Rodin, Rachel M Glicksman, Kathryn Clark, et al.
British Journal of Haematology|August 2, 2012
Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literatureHany R Guirguis, Matthew C Cheung, Mervat Mahrous, et al.
Annals of Hematology|January 14, 2014
Survival of patients with transformed lymphoma in the rituximab eraHany R Guirguis, Matthew C Cheung, Eugenia Piliotis, et al.
BMC Cancer|November 5, 2022
Primary care utilization for patients with newly diagnosed cancer during the COVID-19 pandemic: a population-based studyYing Ling, Matthew C Cheung, Kelvin K W Chan, et al.
BMJ Open|November 3, 2021
Importance of accounting for loss to follow-up when comparing mortality between immigrants and long-term residents: a population-based retrospective cohortManav V Vyas, Jiming Fang, Peter C Austin, et al.
Intensive Care Medicine|September 14, 2021
Critical illness in patients with hematologic malignancy: a population-based cohort studyBruno L Ferreyro, Damon C Scales, Hannah Wunsch, et al.
Cancer Medicine|December 1, 2021
Examining the association between oncology drug clinical benefit and the time to public reimbursementSasha Thomson, Louis Everest, Noah Witzke, et al.
Journal of the National Cancer Institute|April 28, 2022
An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical TrialsMathew Hall, Vaishali A Krishnanandan, Matthew C Cheung, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2021
Assessing the benefit of cancer drugs approved by the European Medicines Agency using the European Society for Medical Oncology Magnitude of Clinical Benefit Scale over timeSasha Thomson, Noah Witzke, Bishal Gyawali, et al.
Annals of Hematology|March 21, 2007
Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphomaMatthew C Cheung, Kevin R Imrie, Heather A Leitch, et al.
Pageof 15